Aquestive Therapeutics, Inc. (AQST)
NASDAQ · Manufacturing · Pharmaceutical preparations
AQST price, last 12 months
Key stats
- Previous close
- $3.78
- Open
- $3.78
- Day range
- $3.67 – $3.87
- 52-week range
- $2.93 – $6.74
- Volume
- 1.4M
- Avg volume (20 days)
- 2.4M
- Market cap
- $491.4M
Performance
Technicals and fundamentals
About Aquestive Therapeutics, Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $491.4M